Lawrence Sherman of the School of Arts and Sciences discusses the “stop and frisk” police procedure.
Penn in the News
Deborah Driscoll of the School of Medicine discusses early pre-natal screening for genetic disorders.
President Amy Gutmann is interviewed about college access and about civility in politics.
David Sarwer of the School of Medicine discusses the link between body dysmorphic disorder and cosmetic surgery.
Penn researchers are cited for studying the side effects of niacin.
Kevin Gillen of the Wharton School says the condo market is declining.
Albert Stunkard of the School of Medicine is cited for research concerning the nature vs. nurture argument in obesity.
Charles Bernstein and Al Filreis of the School of Arts and Sciences discuss the university audio poetry archive, PennSound.
Camille Charles of the School of Arts and Sciences discusses immigration’s effect on affirmative action.
Lance Becker of the School of Medicine says the medical theories surrounding resuscitation may need to be re-examined.
Rebecca Maynard of the Graduate School of Education says some abstinence studies are flawed.
Penn nurses are featured in the exhibit “Just a Nurse.”
At a Cambridge forum, President Amy Gutmann discusses access to higher education.
Jeremy Siegel of the Wharton School discusses index funds.
Jack Guttentag of the Wharton School discusses lender strategies.
John Jackson of the School of Arts and Science reviews Jeff Wiltes's “Contested Waters.”
Witold Rybczynski of the School of Design and the Wharton School is profiled for his book “Last Harvest.”
Gerald Porter of the School of Arts and Sciences discusses a resolution urging Warren Buffett's Berkshire Hathaway Inc. to sell its stake in PetroChina due to a moral dilemma with the Sudanese government.
Brooks Jackson and Kathleen Hall Jamieson of the Annenberg School for Communication are cited for their founding of FactCheck.org and for their new book, “Unspun: Findings Facts in a World of Disinformation.”
Michael Useem of the Wharton School discusses ethics dilemmas in a Gates Foundation stock merger.